The efficacy of Yiqi Huoxue method in treating coronary artery disease after percutaneous coronary intervention: A meta-analysis in accordance with PRISMA guideline

Percutaneous coronary intervention (PCI), the most common method in treating coronary artery disease (CAD), has a variety of side effects. Yiqi Huoxue therapy (YQHX) can effectively alleviate the symptoms of patients and reduce the side effects. However, a reliable and systematic assessment of the m...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Miao, Sun, Ming-Yue, Chen, Qi-Ting, Xu, Feng-Qin, Chen, Zong-Zheng, Wei, Wen-Bo, Wang, Rui-Ting, Xu, Gui-Peng, Yin, Hui-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575818/
https://www.ncbi.nlm.nih.gov/pubmed/36254054
http://dx.doi.org/10.1097/MD.0000000000030739

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9575818/
https://www.ncbi.nlm.nih.gov/pubmed/36254054
http://dx.doi.org/10.1097/MD.0000000000030739

Ejemplares similares